scholarly journals Impact of Acid Suppression Therapy on Iron Supplementation in the Pediatric Intensive Care Unit

2021 ◽  
Vol 26 (4) ◽  
pp. 366-371
Author(s):  
Emily Hailstone ◽  
Sheryl Falkos ◽  
Rosa Vidal ◽  
K. Ashley Jones ◽  
Philippe R. Gaillard ◽  
...  

OBJECTIVE We assessed the impact of acid suppression therapy (i.e., ranitidine or proton pump inhibitors) on iron supplementation and its ability to maintain or alter laboratory values that are commonly associated with anemia. METHODS This was a prospective, observational trial. The primary outcome was changes in serum iron levels from baseline. Secondary outcomes were changes in hemoglobin (Hgb) and hematocrit (Hct), transfusions, and maintenance of an alkalotic gastric pH. RESULTS Thirty-four patients (mean 24 ± 43 months) met inclusion criteria. The serum iron levels increased to 50.9 ± 24.6 mcg/dL by day 3. The mean difference from baseline was 1.5 mcg/dL (95% CI, 1.14–1.98, p = 0.0056). Gastric pH increased to 4.68 ± 1.49 on day 5. The mean Hgb and Hct increased on day 5 to 10 ± 1.06 g/dL and 29.6% ± 3.27%, respectively. The mean difference of Hgb was 1.15 g/dL (95% CI, 0.51–1.78, p = 0.0009). The mean difference of Hct was 3.04% (95% CI, 1.11–4.97, p = 0.0032). CONCLUSIONS The use of antacids along with oral ferrous sulfate supplementation did not affect the absorption of iron. Serum iron, Hgb, and Hct all showed statistically significant increases despite combined antacid and iron therapy. Thus, despite use of antacids, combination use showed increases in iron absorption.

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Lauri Raittio ◽  
Antti Launonen ◽  
Ville M. Mattila ◽  
Aleksi Reito

Abstract Background Randomized controlled trials in orthopaedics are powered to mainly find large effect sizes. A possible discrepancy between the estimated and the real mean difference is a challenge for statistical inference based on p-values. We explored the justifications of the mean difference estimates used in power calculations. The assessment of distribution of observations in the primary outcome and the possibility of ceiling effects were also assessed. Methods Systematic review of the randomized controlled trials with power calculations in eight clinical orthopaedic journals published between 2016 and 2019. Trials with one continuous primary outcome and 1:1 allocation were eligible. Rationales and references for the mean difference estimate were recorded from the Methods sections. The possibility of ceiling effect was addressed by the assessment of the weighted mean and standard deviation of the primary outcome and its elaboration in the Discussion section of each RCT where available. Results 264 trials were included in this study. Of these, 108 (41 %) trials provided some rationale or reference for the mean difference estimate. The most common rationales or references for the estimate of mean difference were minimal clinical important difference (16 %), observational studies on the same subject (8 %) and the ‘clinical relevance’ of the authors (6 %). In a third of the trials, the weighted mean plus 1 standard deviation of the primary outcome reached over the best value in the patient-reported outcome measure scale, indicating the possibility of ceiling effect in the outcome. Conclusions The chosen mean difference estimates in power calculations are rarely properly justified in orthopaedic trials. In general, trials with a patient-reported outcome measure as the primary outcome do not assess or report the possibility of the ceiling effect in the primary outcome or elaborate further in the Discussion section.


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
E Karataş ◽  
B E Temiz ◽  
S Mumusoglu ◽  
H Yarali ◽  
G Bozdag

Abstract Study question Does utilization of dienogest make any impact on the size of cyst and Anti-Müllerian Hormone (AMH) concentration in patients with endometrioma throughout 12-months? Summary answer Although dienogest makes a gradual reduction in the size of endometrioma cyst throughout 12-months, a significant drop in AMH serum concentration was also noticed. What is known already According to recent studies, pre-operative serum AMH levels might be illusively increased with parallel to the size of endometrioma which will be a misleading factor while deciding to operate the patient via cystectomy. Although dienogest is one of the medical options that might be commenced in patients with endometrioma cyst, there is limited data about its effect on the size of the endometrioma and hence serum AMH concentration throughout 12 months of follow up. Study design, size, duration The current observational cohort study was conducted among patients with endometrioma those treated with dienogest from January 2017 to January 2020. The primary outcome was alteration in diameter of endometrioma cyst at 6th and 12th months of treatment. Secondary outcome was alteration in serum AMH concentration in the same period. Of 104 patients treated with dienogest, 44 patients were excluded due to being treated with any type of surgical intervention during follow up period. Participants/materials, setting, methods A total of 60 patients were recruited for the final analysis. Of them, primary symptom was dysmenorrhea, chronic pelvic pain and menstrual irregularity in 16 (26.7%), 25 (41.7%) and 8 (13.3%) patients, respectively. Eighteen patients (30%) were asymptomatic. As 21 patients had bi-lateral endometrioma, size of the leading cyst was considered to be analyzed for the primary outcome measure. Paired-t test was used for comparison of numerical values and p ≤ 0.05 was taken as statistical significance. Main results and the role of chance The mean age was 31.5±8.0 years. In the time point when dienogest was started, the mean size of the endometrioma was 46.3±17.4 mm. The mean serum AMH concentration was 3.6±2.4 ng/ml. After 6 months of treatment, the mean size of the endometrioma decreased to 38.6±14.0 mm which corresponds to a mean difference of 7.8 mm (95% CI: 3.0 to 12.6; p: 0.003). The respective figure for AMH was 3.3±2.7 ng/ml which corresponds to a mean difference of 0.3 ng/ml (95% CI: –0.2 to 0.8; p: 0.23) at 6 months. After 12 months of treatment, the mean size of the endometrioma was 37.5±15.7 mm which corresponds to a mean difference of 8.9 mm (95% CI: 2.9 to 14.9; p: 0.005) at the end of 12 months. The respective figure for AMH was 2.7±1.9 ng/ml which corresponds to a mean difference of 0.9 ng/ml (95% CI: 0.1 to 1.7; p: 0.045) at the end of 12 months. The mean diameter of endometrioma and AMH concentration did not differ throughout the time period between 6th and 12th months of the treatment. Limitations, reasons for caution Although herein we present the largest data that depicts the alteration of endometrioma cyst and AMH concentration with the application of dienogest, the lack of control group is a limitation that avoids to perform any comparison. Wider implications of the findings: A shrinkage after commencement of treatment suggest that dienogest might present improvement in patients with endometrioma with respect to radiological findings, but further studies are required whether a decline in AMH concentration after 12 months refers to a genuine decrease in ovarian reserve or resolution of misleading high pre-treatment levels. Trial registration number not available


2020 ◽  
pp. 107110072097266
Author(s):  
Joseph T. O’Neil ◽  
Otho R. Plummer ◽  
Steven M. Raikin

Background: Patient-reported outcome measures are an increasingly important tool for assessing the impact of treatments orthopedic surgeons render. Despite their importance, they can present a burden. We examined the validity and utility of a computerized adaptive testing (CAT) method to reduce the number of questions on the Foot and Ankle Ability Measure (FAAM), a validated anatomy-specific outcome measure. Methods: A previously developed FAAM CAT system was applied to the responses of patients undergoing foot and ankle evaluation and treatment over a 3-year period (2017-2019). A total of 15 902 responses for the Activities of Daily Living (ADL) subscale and a total of 14 344 responses for the Sports subscale were analyzed. The accuracy of the CAT to replicate the full-form score was assessed. Results: The CAT system required 11 questions to be answered for the ADL subscale in 85.1% of cases (range, 11-12). The number of questions answered on the Sports subscale was 6 (range, 5-6) in 66.4% of cases. The mean difference between the full FAAM ADL subscale and CAT was 0.63 of a point. The mean difference between the FAAM Sports subscale and CAT was 0.65 of a point. Conclusion: The FAAM CAT was able to reduce the number of responses a patient would need to answer by nearly 50%, while still providing a valid outcome score. This measure can therefore be directly correlated with previously obtained full FAAM scores in addition to providing a foot/ankle-specific measure, which previously reported CAT systems are not able to do. Level of Evidence: Level IV, case series.


Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 1721-1721
Author(s):  
Annette von Drygalski ◽  
Deborah A. Andris ◽  
Scott Jackson ◽  
Peter R. Nuttleman ◽  
J. Klein ◽  
...  

Abstract Bariatric surgery has become an important means to reduce obesity and its related morbidity. Bariatric surgeries in the US have increased from 14,000 in 1998 to 140,000 in 2004. Malabsorption and achlorhydria can complicate bariatric surgery and may lead to iron deficiency and anemia. In this setting, little is known about the prevalence and severity of anemia and the efficacy of oral iron replacement, a common part of post-surgical management. We reviewed the records at our institution of a large number (n=1125; 126 men; 999 women) of patients followed for up to 4 yrs post-procedure for the development of anemia and assessment of vitamin levels and iron stores. METHODS: Body mass index (BMI), hemoglobin (Hb), B12, folate, serum iron and ferritin values were extracted from electronic records of the patients at baseline, and 250 patients (33 men; 217 women) followed out to 4 yrs after Roux-en-Y gastric bypass. Anemia was defined by age- and gender-specific WHO criteria. RESULTS: Mean BMI fell from 50.1 (CI 49.6–50.6) at baseline to 33.1 (CI 29.8–36.4) at 4 yrs. Anemia was present in 12% of all patients at baseline and was similar between men (9%) and women (12%). At 18mos, 29% of woman <50yrs of age were anemic, compared to 9% of women >50 yrs (p=0.02). For patients followed out to 2–4 yrs, 21% were anemic and women <50 yrs were most affected (29%) compared to women >50 yrs (15%; p=0.02). The incidence of anemia among men did not change over the period of observation. In all patients the mean Hb decreased from 13.4 g/dL (CI 13.3–13.5) at baseline to 12.1 g/dL (CI 11.1–13.1; p<0.05) at 4yrs. Mean Hb in anemics was 10.4 g/dL. Baseline ferritin was 87 ng/mL (CI 75.2–99.7) for all patients and fell to 66 ng/mL(CI 51.2–80.0) at 18mos and 55 ng/mL (CI 43.3–66.2) by 2–4yrs. The percent of patients with ferritins <50 and <20 ng/mL at baseline were 23 and 11, respectively, and, of these, 15 and 25% were anemic. By yr 4, the percent of patients with ferritins <50 ng/mL rose to 66 and 21% were anemic; the percent with ferritin <20 was 4% and 33% were anemic. Again, women <50 yrs were most at risk with a mean ferritin of 35 ng/mL (CI 21.8–48.2); of these 5% had a ferritin <20 ng/mL and 37% of those were anemic. Of women > 50 years, the mean ferritin was 63 ng/mL (CI 45.3–80.5); 54% had ferritins <50 ng/mL and, of these, only 15% were anemic (p=0.04). Of the 4% with a ferritin <20 ng/mL, 25% were anemic. Mean B12 and folate levels remained stable and did not correlate with anemia. In contrast to ferritin, mean serum iron values did not decrease. Interpretation of this finding is difficult since total iron binding capacity was not measured simultaneously and supplemental iron intake might be confounding. CONCLUSIONS: although oral iron, folate and vitamin B12 supplements were routinely prescribed after surgery, anemia was a common complication and its frequency increased with time. Negative iron balance was progressive, despite oral iron supplementation. While iron deficiency did not account for all cases of anemia, it is sufficiently common to warrant careful evaluation of the ability of bariatric patients to absorb iron and/or comply with life-long oral iron supplementation. Given the rapidly increasing number of bariatric procedures in the US, all physicians should be alerted to the possible need for parenteral iron therapy to prevent anemia and its complications.


2015 ◽  
Vol 39 (6) ◽  
pp. 795-811 ◽  
Author(s):  
Misook Heo ◽  
Natalie Toomey

Purpose – The purpose of this paper is to investigate the impact of system-generated visual feedback and continued contribution on individuals’ motivation to share knowledge in a crowdsourcing environment. Design/methodology/approach – An experimental setting was designed to investigate participants’ motivation to contribute knowledge in a crowdsourcing environment. Responses from a total of 101 participants were analyzed. The independent variables were visual feedback and time. The dependent variable was the participants’ self-expressed willingness to further contribute in the experimental knowledge-sharing activity. Findings – A significant main effect of time was found, showing overall gains in the mean willingness to participate over time. It was also found that the mean willingness of the control and top assimilation groups were higher than the mean willingness of the rank contrast and status groups. The mean difference obtained for the control group was mainly during the first half of the knowledge-sharing tasks, while the mean difference obtained for the top assimilation group was mainly during the second half of the knowledge-sharing tasks. Originality/value – This study contributes to the literature related to motivation in knowledge sharing by providing theory-based, empirical evidence of the potential for external interventions to improve willingness to contribute and sustain knowledge sharing. The findings additionally provide practical implications for motivating and sustaining knowledge sharing.


2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Janko Samardzic ◽  
Anne Smits ◽  
Isabel Spriet ◽  
Ivan Soldatovic ◽  
Andrew Atkinson ◽  
...  

Substantial interassay variability (up to 20%) has been described for vancomycin immunoassays in adults, but the impact of neonatal matrix is difficult to quantify because of blood volume constraints in neonates. However, we provide circumstantial evidence for a similar extent of variability. Using the same vancomycin dosing regimens and confirming similarity in clinical characteristics, vancomycin trough concentrations measured by PETINIA (2011-2012,n=400) were 20% lower and the mean difference was 1.93 mg/L compared to COBAS (2012–2014,n=352) measurements. The impact of vancomycin immunoassays in neonatal matrix was hereby suggested, supporting a switch to more advanced techniques (LC-MS/MS).


2019 ◽  
Vol 37 (04) ◽  
pp. 415-420
Author(s):  
Osayame A. Ekhaguere ◽  
Michael A. Padula ◽  
Erik A. Jensen

Objective The use of acid suppression therapies in newborns lacks efficacy and is associated with adverse effects. Point-of-care (POC) assessment of gastric aspirate pH may provide an objective, noninvasive measure of gastric acidity in tube fed infants. We conducted the present study to characterize the POC gastric pH levels in gastric tube fed infants before and after initiation of enteral omeprazole or ranitidine. Study Design Retrospective cohort study of infants with gastric aspirate pH levels determined by POC pH strips. Gastric pH levels recorded during 7 days before and 14 days after medication initiation were compared using Wilcoxon's sign-rank tests. Results Among 307 evaluated infants, 284 (92%) had a median gastric pH level ≥4 in 7 days prior to ranitidine or omeprazole. In 14 days after medication initiation, the median gastric pH of infants with pretreatment median gastric pH < 4 increased to 4.5 and 5 (p < 0.01) in the ranitidine and omeprazole groups, respectively. There was no change in infants with pretreatment median gastric pH ≥4. Conclusion Among infants receiving gastric tube feedings and enteral omeprazole or ranitidine, only those with a pretreatment gastric pH level <4 demonstrated a significant increase in gastric pH. Validation of our findings against esophageal pH multichannel intraluminal impedance testing is needed.


2007 ◽  
Vol 28 (9) ◽  
pp. 1025-1029 ◽  
Author(s):  
Jerome I. Tokars ◽  
R. Monina Klevens ◽  
Jonathan R. Edwards ◽  
Teresa C. Horan

Objective.To describe methods to assess the practical impact of risk adjustment for central line-days on the interpretation of central line–associated bloodstream infection (BSI) rates, because collecting these data is often burdensome.Methods.We analyzed data from 247 hospitals that reported to the adult and pediatric intensive care unit component of the National Nosocomial Infections Surveillance System from 1995 through 2003. For each unit each year, we calculated the percentile error as the absolute value of the difference between the percentile based on a risk-adjusted or more-sophisticated measure (eg, the central line–day rate) and the percentile based on a crude or less-sophisticated measure (eg, the patient-day rate). Using rate per central line–day as the “gold standard,” we calculated performance characteristics (eg, sensitivity and predictive values) of rate per patient-day for finding central line–associated BSI rates higher or lower than the mean. Greater impact of risk adjustment is indicated by higher values for percentile error and lower values for performance characteristics.Results.The median percentile error was ± 7 (ie, the percentile based on central line-days could be 7% higher or lower than the percentile based on patient-days). This error was less than 10 percentile points for 62% of the unit-years, was between 10 and 19 percentile points for 22% of the unit-years, and was 20 percentile points or more for 15% of the unit-years. Use of the rate based on patient-days had a sensitivity of 76% and a positive predictive value of 61% for detecting a significantly high or low central line–associated BSI rate.Conclusions.We found that risk adjustment for central line–days has an important impact on the calculated central line–associated BSI percentile for some units. Similar methods can be used to evaluate the impact of other risk adjustment methods. Our results support current recommendations to use central line–days for surveillance of central line–associated BSI when comparisons are made among facilities.


2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Claudia Dziegielewski ◽  
Charlenn Skead ◽  
Toros Canturk ◽  
Colleen Webber ◽  
Shannon M. Fernando ◽  
...  

Purpose. Delirium frequently affects critically ill patients in the intensive care unit (ICU). The purpose of this study is to evaluate the impact of delirium on ICU and hospital length of stay (LOS) and perform a cost analysis. Materials and Methods. Prospective studies and randomized controlled trials of patients in the ICU with delirium published between January 1, 2015, and December 31, 2020, were evaluated. Outcome variables including ICU and hospital LOS were obtained, and ICU and hospital costs were derived from the respective LOS. Results. Forty-one studies met inclusion criteria. The mean difference of ICU LOS between patients with and without delirium was significant at 4.77 days ( p < 0.001 ); for hospital LOS, this was significant at 6.67 days ( p < 0.001 ). Cost data were extractable for 27 studies in which both ICU and hospital LOS were available. The mean difference of ICU costs between patients with and without delirium was significant at $3,921 ( p < 0.001 ); for hospital costs, the mean difference was $5,936 ( p < 0.001 ). Conclusion. ICU and hospital LOS and associated costs were significantly higher for patients with delirium, compared to those without delirium. Further research is necessary to elucidate other determinants of increased costs and cost-reducing strategies for critically ill patients with delirium. This can provide insight into the required resources for the prevention of delirium, which may contribute to decreasing healthcare expenditure while optimizing the quality of care.


Sign in / Sign up

Export Citation Format

Share Document